Boothbay Fund Management, LLC Pharvaris N.V. Transaction History
Boothbay Fund Management, LLC
- $4.45 Billion
- Q2 2025
A detailed history of Boothbay Fund Management, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 16,187 shares of PHVS stock, worth $376,347. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,187Holding current value
$376,347% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PHVS
# of Institutions
58Shares Held
39.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$175 Million4.61% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$103 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$99.7 Million79.45% of portfolio
-
Viking Global Investors LP3.65MShares$84.9 Million0.2% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$76.8 Million17.44% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $785M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...